Viatris Inc
VTRSPharma & biotechviatris.com
Latest available resultsSeptember 30, 2026Quarter · 10-Q filed Nov 5, 2026
Next reportFebruary 24, 2027after close · forecast 0.608 $/share
Revenue
$3.75B
▼ -0.3% vs prior year YoY
Net income
—
EPS
-0.28$
▼ -154.5% vs prior year YoY
Net margin
—
Revenue▼ -0.3%
Margins (% of revenue)GrossOperatingNet N/A
Net income
N/ANot reported for the displayed periods
EPS▼ -154.5%
Financial statements
View 10-Q filed November 5, 2026 on SEC ↗| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $3.53B | $3.25B | $3.58B | $3.76B | $3.70B | $3.52B | $3.76B | $3.75B | ▼ -0.3% |
| Gross profit | $1.22B | $1.16B | $1.33B | $1.37B | $1.15B | $1.16B | $1.46B | $1.44B | ▲ +4.8% |
| Operating income | −$179.80M | −$2.88B | $233.00M | $178.80M | −$192.70M | −$79.70M | $6.30M | $261.50M | ▲ +46.3% |
| Net income | — | — | — | — | — | — | — | — | — |
| R&D | — | $222.00M | $218.80M | $250.40M | — | $248.60M | $248.30M | $231.70M | ▼ -7.5% |
| EPS (diluted) | — | -2.55 $ | 0.00 $ | -0.11 $ | — | 0.15 $ | -0.10 $ | -0.28 $ | ▼ -154.5% |
| Margins (% of revenue) | |||||||||
| Gross | 34.4 % | 35.7 % | 37.2 % | 36.5 % | 31.0 % | 32.9 % | 38.8 % | 38.4 % | ▲ +1.9 pt |
| Operating | -5.1 % | -88.6 % | 6.5 % | 4.8 % | -5.2 % | -2.3 % | 0.2 % | 7.0 % | ▲ +2.2 pt |
| Net | — | — | — | — | — | — | — | — | — |
| Balance sheet | |||||||||
| Assets | $41.50B | $38.47B | $38.41B | $37.92B | $37.19B | $36.83B | $35.04B | $34.68B | ▼ -8.5% |
| Liabilities | $22.87B | $22.82B | $22.84B | $22.70B | $22.48B | $22.18B | $20.78B | $21.00B | ▼ -7.5% |
| Equity | $18.64B | $15.65B | $15.57B | $15.22B | $14.71B | $14.66B | $14.26B | $13.69B | ▼ -10.1% |
| Cash | $734.80M | $755.00M | $566.40M | $975.30M | $1.32B | $1.80B | $886.50M | $1.79B | ▲ +83.5% |
| Capital | |||||||||
| Shares outstanding | 1.19B | 1.17B | 1.17B | 1.15B | 1.15B | 1.16B | 1.15B | 1.15B | ▼ -0.5% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.